drugset / Trial / NCT07093268
Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety and tolerability of intrathecal riluzole in adults with amyotrophic lateral sclerosis.
Timeline
- Start
- 2025-08-15
- Primary completion
- 2026-06-15
- Completion
- 2027-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riluzole | Small molecule | 0.2 mg | Intrathecal |